Journal of Neuroimmunology
Volume 185, Issue 1 , Pages 190-194 , April 2007

Proteome analysis of cerebrospinal fluid in Guillain–Barré syndrome (GBS)

  • V. Lehmensiek

      Affiliations

    • Department of Neurology, University of Ulm, Oberer Eselsberg 45, 89081 Ulm, Germany
  • ,
  • S.D. Süssmuth

      Affiliations

    • Department of Neurology, University of Ulm, Oberer Eselsberg 45, 89081 Ulm, Germany
  • ,
  • J. Brettschneider

      Affiliations

    • Department of Neurology, University of Ulm, Oberer Eselsberg 45, 89081 Ulm, Germany
  • ,
  • G. Tauscher

      Affiliations

    • Department of Neurology, University of Ulm, Oberer Eselsberg 45, 89081 Ulm, Germany
  • ,
  • S. Felk

      Affiliations

    • Boehringer Ingelheim Pharma GmbH and Co.KG, CNS Research, 88397 Biberach an der Riss, Germany
  • ,
  • F. Gillardon

      Affiliations

    • Boehringer Ingelheim Pharma GmbH and Co.KG, CNS Research, 88397 Biberach an der Riss, Germany
  • ,
  • H. Tumani

      Affiliations

    • Department of Neurology, University of Ulm, Oberer Eselsberg 45, 89081 Ulm, Germany
    • Corresponding Author InformationCorresponding author. Tel.:+49 731 1775204; fax:+49 731 1771519.

Received 4 October 2006 ,Revised 24 January 2007 ,Accepted 29 January 2007.

References 

  1. Allen S, Heath PR, Kirby J, Wharton SB, Cookson MR, Menzies FM, et al. Analysis of the cytosolic proteome in a cell culture model of familial amyotrophic lateral sclerosis reveals alterations to the proteasome, antioxidant defenses, and nitric oxide synthetic pathways. J. Biol. Chem. 2003;278:6371–6383
  2. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain–Barre syndrome. Ann. Neurol. 1990;27:S21–S24Suppl
  3. Chamoun V, Zeman A, Blennow K, Fredman P, Wallin A, Keir G, et al. Haptoglobins as markers of blood-CSF barrier dysfunction: the findings in normal CSF. J. Neurol. Sci. 2001;182:117–121
  4. Chopra B, Abraham R, Abraham A. CSF beta-1 Globulin — a potential marker in differentiating multiple sclerosis and acute disseminated encephalomyelitis: a preliminary study. Neurol. India. 2002;50:41–44
  5. Czogalla A, Sikorski AF. Spectrin and calpain: a ‘target’ and a ‘sniper’ in the pathology of neuronal cells. Cell. Mol. Life Sci. 2005;62:1913–1924
  6. Dabrowska R, Kulikova N, Gagola M. Nonmuscle caldesmon: its distribution and involvement in various cellular processes. Review article. Protoplasma. 2004;224:1–13
  7. Daude N, Ellie E, Reichardt JK, Petry KG. In vivo and in vitro expression of rat galactose-1-phosphate uridyltransferase (GALT) in the developing central and peripheral nervous system. Brain Res. Dev. Brain Res. 1996;94:190–196
  8. Gutowski NJ, Pinkham JM, Akanmu D, Chirico S, Murphy RP. Free radicals in inflammatory neurological disease: increased lipid peroxidation and haptoglobin levels in Guillain Barre syndrome. Ir. J. Med. Sci. 1998;167:43–46
  9. Hammack BN, Fung KY, Hunsucker SW, Duncan MW, Burgoon MP, Owens GP, et al. Proteomic analysis of multiple sclerosis cerebrospinal fluid. Mult. Scler. 2004;10:245–260
  10. Hughes RA, Cornblath DR. Guillain–Barre syndrome. Lancet. 2005;366:1653–1666
  11. Kleyweg RP, van der Meche FG, Schmitz PI. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain–Barre syndrome. Muscle Nerve. 1991;14:1103–1109
  12. Lehmensiek, V., Süssmuth, S., Tauscher, G., Brettschneider, J., Felk, S., Gillardon, F., Tumani, H., in press. Cerebrospinal fluid proteome profile in Multiple Sclerosis. Mult Scler.
  13. Marchi N, Fazio V, Cucullo L, Kight K, Masaryk T, Barnett G, et al. Serum transthyretin monomer as a possible marker of blood-to-CSF barrier disruption. J. Neurosci. 2003;23:1949–1955
  14. Matsumura F, Yamashiro S. Caldesmon. Curr. Opin. Cell Biol. 1993;5:70–76
  15. McCombe PA, Clark P, Frith JA, Hammond SR, Stewart GJ, Pollard JD, et al. Alpha-1 antitrypsin phenotypes in demyelinating disease: an association between demyelinating disease and the allele PiM3. Ann. Neurol. 1985;18:514–516
  16. Ogawa Y, Schafer DP, Horresh I, Bar V, Hales K, Yang Y, et al. Spectrins and ankyrinB constitute a specialized paranodal cytoskeleton. J. Neurosci. 2006;26:5230–5239
  17. Pengal RA, Ganesan LP, Wei G, Fang H, Ostrowski MC, Tridandapani S. Lipopolysaccharide-induced production of interleukin-10 is promoted by the serine/threonine kinase Akt. Mol. Immunol. 2006;43:1557–1564
  18. Rylander MN, Feng Y, Zhang Y, Bass J, Jason Stafford R, Volgin A, et al. Optimizing heat shock protein expression induced by prostate cancer laser therapy through predictive computational models. J. Biomed. Opt. 2006;11:041113
  19. Sadrzadeh SM, Bozorgmehr J. Haptoglobin phenotypes in health and disorders. Am. J. Clin. Pathol. 2004;121:S97–S104
  20. Schwagerl AL, Mohan PS, Cataldo AM, Vonsattel JP, Kowall NW, Nixon RA. Elevated levels of the endosomal-lysosomal proteinase cathepsin D in cerebrospinal fluid in Alzheimer disease. J. Neurochem. 1995;64:443–446
  21. Tsukuba T, Okamoto K, Yasuda Y, Morikawa W, Nakanishi H, Yamamoto K. New functional aspects of cathepsin D and cathepsin E. Mol. Cells. 2000;10:601–611
  22. Yonekura K, Yokota S, Tanaka S, Kubota H, Fujii N, Matsumoto H, et al. Prevalence of anti-heat shock protein antibodies in cerebrospinal fluids of patients with Guillain–Barre syndrome. J. Neuroimmunol. 2004;156:204–209
  23. Zheng S, Cao J, Geng L. Structure and expression of colorectal cancer related immunoglobulin novel gene SNC73. Zhonghua Yi Xue Za Zhi. 2001;81:485–488

PII: S0165-5728(07)00037-9

doi: 10.1016/j.jneuroim.2007.01.022

Journal of Neuroimmunology
Volume 185, Issue 1 , Pages 190-194 , April 2007